This study proposes an innovative and scalable solution to increase oral bioavailability of therapeutic peptides using a combination of lipid-based formulation, hydrophobic ion pairing, permeation enhancer and customized enteric capsules. Poster presented at the 5th European Conference on Pharmaceutics 2025.
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.
Latest briefing from the Knowledge Center